We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

36 hedge funds and large institutions have $2.57M invested in Microbot Medical in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more capital invested

Capital invested by funds: $1.41M → $2.57M (+$1.15M)

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

63% more call options, than puts

Call options by funds: $109K | Put options by funds: $67K

13% more funds holding

Funds holding: 32 → 36 (+4)

4.68% more ownership

Funds ownership: 8.57% → 13.26% (+4.7%)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

Holders
36
Holders Change
+4
Holders Change %
+12.5%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
8
Closed
5
Calls
$109K
Puts
$67K
Net Calls
+$42K
Net Calls Change
+$28K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$399K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$264K
3
HF
HRT Financial
New York
+$77.2K
4
Morgan Stanley
Morgan Stanley
New York
+$34.7K
5
TSS
Two Sigma Securities
New York
+$27K

Top Sellers

Rank Fund Capital Flow
1
Bank of New York Mellon
Bank of New York Mellon
New York
-$71.4K
2
Citadel Advisors
Citadel Advisors
Florida
-$44.6K
3
Renaissance Technologies
Renaissance Technologies
New York
-$23.4K
4
CAN
Cetera Advisor Networks
California
-$15K
5
BAM
Byrne Asset Management
New Jersey
-$5.06K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$1.92K +$9 +7 +0.6%
ASN
27
Advisory Services Network
Georgia
$820 +$666 +500 New
Osaic Holdings
28
Osaic Holdings
Arizona
$336 -$270 -203 -50%
Bank of America
29
Bank of America
North Carolina
$16 +$11 +8 +400%
UBS Group
30
UBS Group
Switzerland
$11 -$1 -1 -13%
BCM
31
Bourgeon Capital Management
Connecticut
$5 -$11 -8 -73%
Barclays
32
Barclays
United Kingdom
$2 – – –
FRA
33
Front Row Advisors
California
$2 – – –
NFSG
34
Newbridge Financial Services Group
Florida
$2 – – –
PCFFS
35
Pacific Center for Financial Services
California
$2 – – –
NA
36
NewEdge Advisors
Louisiana
$2 +$1 +1 New
Bank of New York Mellon
37
Bank of New York Mellon
New York
– -$71.4K -51,346 Closed
CAN
38
Cetera Advisor Networks
California
– -$15K -10,800 Closed
CG
39
Cutler Group
California
– -$133 -100 Closed
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
– -$55 -41 -41%
Northwestern Mutual Wealth Management
41
Northwestern Mutual Wealth Management
Wisconsin
– -$1 -1 Closed
1
2

MBOT Hedge Fund Activity: Q4 2023 in Review

36 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q4 2023, worth a combined $2.57M — up 81% from $1.41M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new MBOT positions and 5 closed out — a net gain of 4 holders — while 8 added to existing stakes and 8 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $399K. The largest seller was Bank of New York Mellon, exiting entirely with an estimated $71.4K sold.

  • 36 institutional investors held Microbot Medical (MBOT) as of Q4 2023, up from 32 in Q3 2023.
  • Funds reported $2.57M of Microbot Medical stock for Q4 2023, up 81% quarter-over-quarter.
  • 9 funds opened new Microbot Medical positions in Q4 2023 and 5 closed out, a net change of +4 holders.
  • The largest Microbot Medical buyer in Q4 2023 was Armistice Capital, an estimated $399K added.
  • The largest Microbot Medical seller in Q4 2023 was Bank of New York Mellon, an estimated $71.4K sold.

Based on aggregated 13F filings for Q4 2023.